Eva Baecklund

7.9k total citations · 1 hit paper
75 papers, 4.9k citations indexed

About

Eva Baecklund is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Eva Baecklund has authored 75 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Rheumatology, 34 papers in Pathology and Forensic Medicine and 32 papers in Genetics. Recurrent topics in Eva Baecklund's work include Chronic Lymphocytic Leukemia Research (32 papers), Lymphoma Diagnosis and Treatment (32 papers) and Rheumatoid Arthritis Research and Therapies (29 papers). Eva Baecklund is often cited by papers focused on Chronic Lymphocytic Leukemia Research (32 papers), Lymphoma Diagnosis and Treatment (32 papers) and Rheumatoid Arthritis Research and Therapies (29 papers). Eva Baecklund collaborates with scholars based in Sweden, United States and Denmark. Eva Baecklund's co-authors include Johan Askling, Lars Klareskog, Nils Feltelius, Karin E. Smedby, Christer Sundström, Carin Backlin, Richard Rosenquist, Anders Ekbom, Anca I. Catrina and Anders Ekbom and has published in prestigious journals such as International Journal of Cancer, Annals of the Rheumatic Diseases and Transplantation.

In The Last Decade

Eva Baecklund

72 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

2006 667 citations Eva Baecklund, Johan Askling et al. Arthritis & Rheumatism profile →

Peers

Countries citing papers authored by Eva Baecklund

Since Specialization

Citations

This map shows the geographic impact of Eva Baecklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Baecklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Baecklund more than expected).

Fields of papers citing papers by Eva Baecklund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Baecklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Baecklund. The network helps show where Eva Baecklund may publish in the future.

Co-authorship network of co-authors of Eva Baecklund

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Baecklund. A scholar is included among the top collaborators of Eva Baecklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Baecklund. Eva Baecklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis 2023 ·Lara D. Veeken ·(unknown), Saedís Saevarsdóttir, Lina-Marcela Díaz-Gallo, (unknown), Lars Alfredsson, Lars Klareskog, Eva Baecklund, Lena Björkman, Alf Kastbom, Solbritt Rantapää‐Dahlqvist, Carl Turesson, Ingileif Jónsdóttir, Kāri Stefánsson, Thomas Frisell, Leonid Padyukov, Johan Askling, Helga Westerlind	1
2	Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance 2023 ·Therapeutic Advances in Musculoskeletal Disease ·George Karpouzas, Zoltán Szekanecz, Eva Baecklund, Ted R. Mikuls, Deepak L. Bhatt, Cunshan Wang, (unknown), Yan Chen, Sujatha Menon, Carol A. Connell, Steven R. Ytterberg, (unknown)	16
3	Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study 2022 ·RMD Open ·René Cordtz, Johan Askling, Bénédicte Delcoigne, Karin E. Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Björn Guðbjörnsson, Þorvarður Jón Löve, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren	2
4	POS0637 SAFETY OF b/tsDMARDs FOR RA AS USED IN CLINICAL PRACTICE - RESULTS FROM THE LAST DECADE OF THE ARTIS PROGRAM 2022 ·Annals of the Rheumatic Diseases ·Thomas Frisell, Hannah Bower, Eva Baecklund, Daniela Di Giuseppe, Bénédicte Delcoigne, Nils Feltelius, (unknown), Elisabet Lindqvist, Ulf Lindström, Johan Askling	2
5	Does being exposed to an educational tool influence patient preferences? The influence of an educational tool on patient preferences assessed by a discrete choice experiment. 2021 ·Patient Education and Counseling ·(unknown), Jorien Veldwijk, Mats Hansson, Eva Baecklund, Karim Raza, Marie Falahee, Ulrik Kihlbom	9
6	Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders 2021 ·Acta Oncologica ·Amelie Kinch, Eva Baecklund, Daniël G. M. Molin, Karlis Pauksens, Christer Sundström, Gunnar Tufveson, Gunilla Enblad	2
7	POS1169 IMPACT OF THE COVID-19 PANDEMIC ON MORBIDITY AND MORTALITY AMONG SWEDISH PATIENTS WITH INFLAMMATORY JOINT DISEASES VERSUS THE GENERAL POPULATION 2021 ·Annals of the Rheumatic Diseases ·Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Alenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad‐d’Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling	1
8	Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs—a Swedish cohort study of risks by time, drug and lymphoma subtype 2020 ·Lara D. Veeken ·Karin Hellgren, Daniela Di Giuseppe, Karin E. Smedby, Christer Sundström, Johan Askling, Eva Baecklund, (unknown)	27
9	Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome 2019 ·Acta Oncologica ·(unknown), Antonios Valachis, (unknown), (unknown), (unknown), Max Flogegård, Eva Baecklund, Gunilla Enblad	13
10	Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation 2018 ·Leukemia & lymphoma ·Amelie Kinch, Christer Sundström, Eva Baecklund, Carin Backlin, Daniel Molin, Gunilla Enblad	30
11	Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics 2017 ·Annals of the Rheumatic Diseases ·Thomas Frisell, Eva Baecklund, Karin Lövgren Bengtsson, Daniela Di Giuseppe, Helena Forsblad‐d’Elia, Johan Askling	40
12	Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome 2015 ·The Journal of Rheumatology ·Ann Knight, (unknown), Christer Sundström, Martin Höglund, Carin Backlin, Karin E. Smedby, Johan Askling, Eva Baecklund	6
13	Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments? 2014 ·Annals of the Rheumatic Diseases ·Elizabeth V. Arkema, Jerker Jonsson, Eva Baecklund, Judith Bruchfeld, Nils Feltelius, Johan Askling, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	75
14	Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden 2010 ·American Journal of Transplantation ·Julia F. Simard, Eva Baecklund, Amelie Kinch, C Brattström, (unknown), Daniel Molin, Johanna Adami, Pia Fernberg, H Wilczek, Anders Ekbom, Karin E. Smedby	35
15	QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries 2007 ·Annals of the Rheumatic Diseases ·Tuulikki Sokka, Hannu Kautiainen, S. Toloza, Heidi Mäkinen, Suzanne Verstappen, Merete Lund Hetland, Antonio Naranjo, Eva Baecklund, G. Herborn, R. Rau, Massimiliano Cazzato, Laure Gossec, Vlado Skakić, Feride Göğüş, Stanisław Sierakowski, Barry Bresnihan, Peter C. Taylor, C McClinton, Theodore Pincus	159
16	TNF-antagonist treatment and risk of hospitalisation for cardiovascular disease. Results from the National Swedish Monitoring-Program for Biologies in Ra (ARTIS). 2006 ·Arthritis & Rheumatism ·Johan Askling, Michael Fored, Lena Brandt, Eva Baecklund, L Bertilsson, L Cöster, P. Geborek, L. Jacobsson, Staffan Lindblad, J Lysholm, Solbritt Rantapää‐Dahlqvist, Tore Saxne, Ronald van Vollenhoven, Nils Feltelius, Lars Klareskog	0
17	TNF-antagonist treatment and risk of hospitalisation for infection. Results from the National Swedish Monitoring-Program for Biologics in RA (ARTIS). 2006 ·Arthritis & Rheumatism ·Johan Askling, Michael Fored, Lena Brandt, Eva Baecklund, L Bertilsson, L Cöster, P. Geborek, L. Jacobsson, Staffan Lindblad, J Lysholm, Solbritt Rantapää‐Dahlqvist, Tore Saxne, Ronald van Vollenhoven, Nils Feltelius, Lars Klareskog	1
18	Risk of tuberculosis in rheumatoid arthritis and following anti-TNF treatment. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA 2005 ·Annals of the Rheumatic Diseases ·Johan Askling, C. Michael Fored, Lena Brandt, Eva Baecklund, L Bertilsson, L Cöster, P. Geborek, L. Jacobsson, Staffan Lindblad, J Lysholm, Solbritt Rantapää‐Dahlqvist, Tore Saxne, (unknown), Lars Klareskog, Nils Feltelius	3
19	Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA 2005 ·Annals of the Rheumatic Diseases ·Johan Askling, C. Michael Fored, Lena Brandt, Eva Baecklund, L Bertilsson, L Cöster, P. Geborek, L. Jacobsson, Staffan Lindblad, J Lysholm, Solbritt Rantapää‐Dahlqvist, Tore Saxne, Nils Feltelius, Lars Klareskog	2
20	Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study 1998 ·BMJ ·Eva Baecklund, Anders Ekbom, Pär Sparén, Nils Feltelius, Lars Klareskog	306

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact